Identification of osteoclast-osteoblast coupling factors in humans reveals links between bone and energy metabolism
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of osteoclast-osteoblast coupling factors in humans reveals links between bone and energy metabolism
Authors
Keywords
-
Journal
Nature Communications
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-01-07
DOI
10.1038/s41467-019-14003-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical and translational pharmacology of the cathepsin K inhibitor odanacatib studied for osteoporosis
- (2019) Julie A. Stone et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass
- (2019) Nicolas Bonnet et al. JOURNAL OF CLINICAL INVESTIGATION
- Effect of denosumab on fasting glucose in women with diabetes or prediabetes from the FREEDOM trial
- (2018) Nicola Napoli et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Effects of Long-Term Denosumab on Bone Histomorphometry and Mineralization in Women With Postmenopausal Osteoporosis
- (2018) David W Dempster et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Coupling of Bone Resorption and Formation in Real Time: New Knowledge Gained From Human Haversian BMUs
- (2017) Nicolai Ernlund Lassen et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Association of DPP-4 activity with BMD, body composition, and incident hip fracture: the Cardiovascular Health Study
- (2017) L. D. Carbone et al. OSTEOPOROSIS INTERNATIONAL
- 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
- (2017) Henry G Bone et al. Lancet Diabetes & Endocrinology
- Glucose-dependent insulinotropic polypeptide (GIP) dose-dependently reduces osteoclast differentiation and resorption
- (2016) Guillaume Mabilleau et al. BONE
- Boning up on DPP4, DPP4 substrates, and DPP4-adipokine interactions: Logical reasoning and known facts about bone related effects of DPP4 inhibitors
- (2016) Lorenzo Glorie et al. BONE
- Odanacatib, effects of 16-month treatment and discontinuation of therapy on bone mass, turnover and strength in the ovariectomized rabbit model of osteopenia
- (2016) Le T. Duong et al. BONE
- Effects of long term treatment with high doses of odanacatib on bone mass, bone strength, and remodeling/modeling in newly ovariectomized monkeys
- (2016) L.T. Duong et al. BONE
- Exenatide improves both hepatic and adipose tissue insulin resistance: A dynamic positron emission tomography study
- (2016) Amalia Gastaldelli et al. HEPATOLOGY
- Early reversal cells in adult human bone remodeling: osteoblastic nature, catabolic functions and interactions with osteoclasts
- (2016) Mohamed Essameldin Abdelgawad et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Effects of Long-Term Odanacatib Treatment on Bone Gene Expression in Ovariectomized Adult Rhesus Monkeys: Differentiation From Alendronate
- (2016) Eric S Muise et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Continuous treatment with odanacatib for up to 8 years in postmenopausal women with low bone mineral density: a phase 2 study
- (2016) R. Rizzoli et al. OSTEOPOROSIS INTERNATIONAL
- Association of circulating dipeptidyl-peptidase 4 levels with osteoporotic fracture in postmenopausal women
- (2016) H. Kim et al. OSTEOPOROSIS INTERNATIONAL
- Osteoprotegerin Regulates Pancreatic β-Cell Homeostasis upon Microbial Invasion
- (2016) Yukiko Kuroda et al. PLoS One
- Denosumab Inhibition of RANKL and Insulin Resistance in Postmenopausal Women with Osteoporosis
- (2015) Antonino Lasco et al. CALCIFIED TISSUE INTERNATIONAL
- Osteoprotegerin and Denosumab Stimulate Human Beta Cell Proliferation through Inhibition of the Receptor Activator of NF-κB Ligand Pathway
- (2015) Nagesha Guthalu Kondegowda et al. Cell Metabolism
- Serum dipeptidyl peptidase-4 is associated with multiple vertebral fractures in type 2 diabetes mellitus
- (2015) Masakazu Notsu et al. CLINICAL ENDOCRINOLOGY
- Plasma DPP4 Activities Are Associated With Osteoporosis in Postmenopausal Women With Normal Glucose Tolerance
- (2015) Tianpeng Zheng et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Nuclear factor κB–inducing kinase activation as a mechanism of pancreatic β cell failure in obesity
- (2015) Elisabeth K. Malle et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Effects of Age and Estrogen on Skeletal Gene Expression in Humans as Assessed by RNA Sequencing
- (2015) Joshua N. Farr et al. PLoS One
- MAP-RSeq: Mayo Analysis Pipeline for RNA sequencing
- (2014) Krishna R Kalari et al. BMC BIOINFORMATICS
- Blockade of CD26 Signaling Inhibits Human Osteoclast Development
- (2014) Hiroko Nishida et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures
- (2014) Sofia Movérare-Skrtic et al. NATURE MEDICINE
- featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
- (2013) Y. Liao et al. BIOINFORMATICS
- WNT-LRP5 Signaling Induces Warburg Effect through mTORC2 Activation during Osteoblast Differentiation
- (2013) Emel Esen et al. Cell Metabolism
- Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus
- (2013) Stefan Kiechl et al. NATURE MEDICINE
- Osteopetrosis: genetics, treatment and new insights into osteoclast function
- (2013) Cristina Sobacchi et al. Nature Reviews Endocrinology
- Isolation and characterization of human osteoblasts from needle biopsies without in vitro culture
- (2013) K. Fujita et al. OSTEOPOROSIS INTERNATIONAL
- RSeQC: quality control of RNA-seq experiments
- (2012) Liguo Wang et al. BIOINFORMATICS
- Removing technical variability in RNA-seq data using conditional quantile normalization
- (2012) K. D. Hansen et al. BIOSTATISTICS
- Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture
- (2012) Karol Estrada et al. NATURE GENETICS
- DA-1229, a novel and potent DPP4 inhibitor, improves insulin resistance and delays the onset of diabetes
- (2011) Mi-Kyung Kim et al. LIFE SCIENCES
- TopHat-Fusion: an algorithm for discovery of novel fusion transcripts
- (2011) Daehwan Kim et al. GENOME BIOLOGY
- The Effect of Oral Antidiabetic Agents on A1C Levels: A systematic review and meta-analysis
- (2010) D. Sherifali et al. DIABETES CARE
- Antifracture Efficacy of Currently Available Therapies for Postmenopausal Osteoporosis
- (2010) Jean-Yves Reginster DRUGS
- Signaling and biological effects of glucagon-like peptide 1 on the differentiation of mesenchymal stem cells from human bone marrow
- (2009) C. Sanz et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
- (2009) M. D. Robinson et al. BIOINFORMATICS
- Giant Osteoclast Formation and Long-Term Oral Bisphosphonate Therapy
- (2009) Robert S. Weinstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- In vivo profiling of DPP4 inhibitors reveals alterations in collagen metabolism and accumulation of an amyloid peptide in rat plasma
- (2008) Marco M. Jost et al. BIOCHEMICAL PHARMACOLOGY
- Dipeptidyl Peptidase-4 Inhibition by Vildagliptin and the Effect on Insulin Secretion and Action in Response to Meal Ingestion in Type 2 Diabetes
- (2008) C. Dalla Man et al. DIABETES CARE
- Building bone to reverse osteoporosis and repair fractures
- (2008) Sundeep Khosla et al. JOURNAL OF CLINICAL INVESTIGATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now